Literature DB >> 2260126

Phototoxic potential of quinolone antibacterial agents in Balb/c mice.

N Wagai1, F Yamaguchi, M Sekiguchi, K Tawara.   

Abstract

The phototoxic potentials of quinolone antibacterial agents were investigated in Balb/c strain mice. The mice were orally administered nalidixic acid (NA), enoxacin (ENX), ofloxacin (OFLX), ciprofloxacin (CPFX), lomefloxacin (LMFX) and DR-3355 (s-isomer of OFLX), and immediately exposed to ultraviolet-A (UVA) for 4 h (21.6 joules/cm2). The ears were examined for overt damage, as a major phototoxic parameter, 0, 24 and 48 h after irradiation ended. At doses of 200 mg/kg, LMFX, NA and ENX caused marked cutaneous phototoxic reactions on the ears, whereas CPFX, OFLX and DR-3355 caused none. At 800 mg/kg, however, CPFX, OFLX and DR-3355 also caused phototoxic reactions on the ears. These phototoxic changes were characterized grossly by erythema, and histopathologically by edema and infiltration of inflammatory cells, especially neutrophils, into the connective tissue surrounding the cartilage. The 50% erythema-inducing doses of LMFX, ENX, NA, OFLX, DR-3355 and CPFX were calculated at 19, 102, 143, 553, 619 and 741 mg/kg, respectively. Thus, the phototoxic potencies of the quinolones tested were: LMFX greater than ENX, NA greater than OFLX, DR-3355, CPFX.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260126     DOI: 10.1016/0378-4274(90)90197-t

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  13 in total

1.  Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions.

Authors:  L Naldi; A Conforti; M Venegoni; M G Troncon; A Caputi; E Ghiotto; A Cocci; U Moretti; G Velo; R Leone
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

2.  Adverse reactions induced by NSAIDs and antibacterials: analysis of spontaneous reports from the Sicilian regional database.

Authors:  Giovanni Polimeni; Francesco Salvo; Paola Cutroneo; Ilaria Morreale; Achille Patrizio Caputi
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Comparative tolerability of the newer fluoroquinolone antibacterials.

Authors:  P Ball; L Mandell; Y Niki; G Tillotson
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

4.  Sparfloxacin phototoxicity: potential photoaugmentation by ultraviolet A and B sources.

Authors:  Y Tokura; Y Iwamoto; K Mizutani; M Takigawa
Journal:  Arch Dermatol Res       Date:  1996       Impact factor: 3.017

5.  Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

Authors:  Roberto Leone; Mauro Venegoni; Domenico Motola; Ugo Moretti; Valentina Piazzetta; Alfredo Cocci; Domenico Resi; Federico Mozzo; Giampaolo Velo; Liliana Burzilleri; Nicola Montanaro; Anita Conforti
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Possible direct role of reactive oxygens in the cause of cutaneous phototoxicity induced by five quinolones in mice.

Authors:  N Wagai; K Tawara
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

7.  Photosensitivity reactions caused by lomefloxacin hydrochloride: a multicenter survey.

Authors:  J Arata; T Horio; R Soejima; K Ohara
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

8.  Important role of oxygen metabolites in quinolone antibacterial agent-induced cutaneous phototoxicity in mice.

Authors:  N Wagai; K Tawara
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

9.  Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation.

Authors:  M Matsumoto; K Kojima; H Nagano; S Matsubara; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

10.  Flush induced by fluoroquinolones in canine skin.

Authors:  M Kurata; Y Kasuga; E Nanba; H Nakamura; T Asano; K Haruta
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.